Although CaMKII initially initiates beneficial effects, sustained activity of CaMKII eventually triggers pro‐arrhythmic electrical remodelling and leads to transcription of pro‐hypertrophic genes inducing structural remodelling eventually leading to heart failure (HF). The gene discussed is CAMK2G; the disease is hydrops fetalis.